Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
Wong F, Pappas SC, Curry MP, Reddy KR, Rubin RA, Porayko MK, Gonzalez SA, Mumtaz K, Lim N, Simonetto DA, Sharma P, Sanyal AJ, Mayo MJ, Frederick RT, Escalante S, Jamil K; CONFIRM Study Investigators.
N Engl J Med. 2021 Mar 4;384(9):818-828. doi: 10.1056/NEJMoa2008290.
News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document.
Angeli P, Garcia-Tsao G, Nadim MK, Parikh CR.
J Hepatol. 2019 Oct;71(4):811-822. doi: 10.1016/j.jhep.2019.07.002. Epub 2019 Jul 11.
Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study.
Cavallin M, Piano S, Romano A, Fasolato S, Frigo AC, Benetti G, Gola E, Morando F, Stanco M, Rosi S, Sticca A, Cillo U, Angeli P.
Hepatology. 2016 Mar;63(3):983-92. doi: 10.1002/hep.28396. Epub 2016 Feb 3.
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020.
Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K.
J Gastroenterol. 2021 Jul;56(7):593-619. doi: 10.1007/s00535-021-01788-x. Epub 2021 Jul 7.
Hepatorenal syndrome and type 1 and 2 cardiorenal syndromes: distinct competing medical therapies applied to a similar background of vasomotor reactive nephropathy.
De Vecchis R, Esposito C, Di Biase G, Ariano C.
Minerva Cardioangiol. 2014 Feb;62(1):105-16.
Is type 2 hepatorenal syndrome still a potential indication for treatment with terlipressin and albumin?
Angeli P, Piano S.
Liver Transpl. 2015 Nov;21(11):1335-7. doi: 10.1002/lt.24339.
Hepatorenal syndrome.
Lata J.
World J Gastroenterol. 2012 Sep 28;18(36):4978-84. doi: 10.3748/wjg.v18.i36.4978.
Hepatorenal syndrome.
Angeli P, Morando F, Cavallin M, Piano S.
Contrib Nephrol. 2011;174:46-55. doi: 10.1159/000329235. Epub 2011 Sep 9.
Hepatorenal syndrome.
Demirtaş S, Can M, Yarpuzlu A.
Clin Chem Lab Med. 2006;44(4):379-86. doi: 10.1515/CCLM.2006.062.
Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy.
Iwakiri Y, Trebicka J.
JHEP Rep. 2021 Jun 4;3(4):100316. doi: 10.1016/j.jhepr.2021.100316. eCollection 2021 Aug.
